Beryl Drugs (BOM:524606) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524606 Beryl Drugs Ltd BOM:524606
68 GF Score
Price ₹24.04
GF Value ₹20.66
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Beryl Drugs Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

BOM:524606
68GF Score
Beryl Drugs Ltd BOM:524606
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Beryl Drugs (BOM:524606) Overvalued in 2026?

Based on GuruFocus' analysis, Beryl Drugs stock appears to be overvalued. The current stock price of ₹24.04 is trading 16.4% above its estimated GF Value™ of ₹20.66. GuruFocus considers Beryl Drugs to be Modestly Overvalued.

Key valuation signals for BOM:524606:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: ₹20.66 vs. price of ₹24.04 (16.4% above fair value)
  • GF Score™: 68/100 with 6 warning signs

No single metric tells the full story. See the BOM:524606 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Beryl Drugs Business Description

Address 133, Kanchan Bagh, Ground Floor, Indore, MP, IND, 452001
Beryl Drugs Ltd is a pharmaceutical company principally engaged in the manufacturing and marketing of allopathic pharmaceutical preparations. It also provides contract manufacturing services and veterinary products. It offers manufacturing options for product requirements like small-volume injectables in liquid form, small-volume injectables in dry powder form, eye and ear drops, intravenous fluids in poly pack and glass bottles, and veterinary medicines. The company earns the majority of its revenue from the sale of Bulk Drugs.
68GF Score

Get the complete analysis for BOM:524606

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹24.04
Price
₹20.66
GF Value